Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eng Huat Tan

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Chest|December 15, 2004
The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysisChee-Keong Toh, Ee-Hwee Wong, Wan-Teck Lim, et al.
British Journal of Clinical Pharmacology|April 2, 2005
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancerQingyu Zhou, Alex Sparreboom, Eng-Huat Tan, et al.
British Journal of Clinical Pharmacology|October 15, 2011
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patientsSin Chi Chew, Edwin Sandanaraj, Onkar Singh, et al.
Scientific Reports|May 10, 2017
Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinibSrinivasaraghavan Kannan, Mohan R Pradhan, Garima Tiwari, et al.
Lung Cancer (Amsterdam, Netherlands)|June 2, 2009
A phase II trial of induction gemcitabine and vinorelbine followed by concurrent vinorelbine and radiotherapy in locally advanced non-small cell lung cancerSwan Swan Leong, Kam Weng Fong, Wan Teck Lim, et al.
Chinese Clinical Oncology|April 29, 2016
Advances in systemic treatment for nasopharyngeal carcinomaWan-Ling Tan, Eng-Huat Tan, Darren Wan-Teck Lim, et al.
Respiratory Medicine|November 6, 2004
Chemo-radiotherapy for stage III unresectable non-small cell lung cancer long-term results of a prospective studySwan Swan Leong, Kam Weng Fong, Yew Kwang Ong, et al.
Asia-Pacific Journal of Clinical Oncology|September 28, 2020
Immune checkpoint inhibitor-associated myositis and myasthenia gravis overlap: Understanding the diversity in a case seriesEvelyn Yi Ting Wong, Ming Hui Yong, Kok Pin Yong, et al.
Targeted Oncology|September 9, 2014
Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trialDavid F Heigener, José Rodrigues Pereira, Enriqueta Felip, et al.
Cancer Chemotherapy and Pharmacology|April 7, 2011
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patientsSin-Chi Chew, Onkar Singh, Xiangai Chen, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Chest|December 15, 2004
The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysisChee-Keong Toh, Ee-Hwee Wong, Wan-Teck Lim, et al.
British Journal of Clinical Pharmacology|April 2, 2005
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancerQingyu Zhou, Alex Sparreboom, Eng-Huat Tan, et al.
British Journal of Clinical Pharmacology|October 15, 2011
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patientsSin Chi Chew, Edwin Sandanaraj, Onkar Singh, et al.
Scientific Reports|May 10, 2017
Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinibSrinivasaraghavan Kannan, Mohan R Pradhan, Garima Tiwari, et al.
Lung Cancer (Amsterdam, Netherlands)|June 2, 2009
A phase II trial of induction gemcitabine and vinorelbine followed by concurrent vinorelbine and radiotherapy in locally advanced non-small cell lung cancerSwan Swan Leong, Kam Weng Fong, Wan Teck Lim, et al.
Chinese Clinical Oncology|April 29, 2016
Advances in systemic treatment for nasopharyngeal carcinomaWan-Ling Tan, Eng-Huat Tan, Darren Wan-Teck Lim, et al.
Respiratory Medicine|November 6, 2004
Chemo-radiotherapy for stage III unresectable non-small cell lung cancer long-term results of a prospective studySwan Swan Leong, Kam Weng Fong, Yew Kwang Ong, et al.
Asia-Pacific Journal of Clinical Oncology|September 28, 2020
Immune checkpoint inhibitor-associated myositis and myasthenia gravis overlap: Understanding the diversity in a case seriesEvelyn Yi Ting Wong, Ming Hui Yong, Kok Pin Yong, et al.
Targeted Oncology|September 9, 2014
Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trialDavid F Heigener, José Rodrigues Pereira, Enriqueta Felip, et al.
Cancer Chemotherapy and Pharmacology|April 7, 2011
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patientsSin-Chi Chew, Onkar Singh, Xiangai Chen, et al.
Pageof 11